Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
Molecular and Cellular Biology|April 3, 2004
Rescue of an hTERT mutant defective in telomere elongation by fusion with hPot1Blaine N Armbruster, Corinne M Linardic, Tim Veldman, et al.Scientific Reports|August 14, 2021
Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescenceJenny J Li, Alexander R Kovach, Margaret DeMonia, et al.Frontiers in Oncology|July 25, 2013
Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfallsAshley R P Hinson, Rosanne Jones, Lisa E S Crose, et al.Cancer Research|December 3, 2008
Defining the cooperative genetic changes that temporally drive alveolar rhabdomyosarcomaSarasija Naini, Katherine T Etheridge, Stacey J Adam, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2012
FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcomaLisa E S Crose, Katherine T Etheridge, Candy Chen, et al.Pediatric Blood & Cancer|December 11, 2020
Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom StudiengruppeErin R Rudzinski, Anna Kelsey, Christian Vokuhl, et al.Research Square|November 14, 2023
Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse modelsPeter G Hendrickson, Kristianne M Oristian, MaKenna R Browne, et al.Biorxiv : the Preprint Server for Biology|October 9, 2023
Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse modelsPeter G Hendrickson, Kristianne M Oristian, MaKenna R Browne, et al.Cancer Research|August 11, 2018
Loss of MST/Hippo Signaling in a Genetically Engineered Mouse Model of Fusion-Positive Rhabdomyosarcoma Accelerates TumorigenesisKristianne M Oristian, Lisa E S Crose, Nina Kuprasertkul, et al.Pediatric Blood & Cancer|July 11, 2023
Children's Oncology Group's 2023 blueprint for research: Soft tissue sarcomasSapna Oberoi, Jacquelyn N Crane, Josephine H Haduong, et al.Pageof 6